These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15809340)

  • 1. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
    J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.
    Hansen K; Farkas T; Lukas J; Holm K; Rönnstrand L; Bartek J
    EMBO J; 2001 Feb; 20(3):422-32. PubMed ID: 11157749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic activities of G1 cyclin-dependent kinases and phosphorylation of retinoblastoma protein in mobilized peripheral blood CD34+ hematopoietic progenitor cells.
    Leibundgut K; Schmitz NM; Hirt A
    Stem Cells; 2005 Aug; 23(7):1002-11. PubMed ID: 15941859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
    Li Y; Nichols MA; Shay JW; Xiong Y
    Cancer Res; 1994 Dec; 54(23):6078-82. PubMed ID: 7954450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs.
    Zarkowska T; U S; Harlow E; Mittnacht S
    Oncogene; 1997 Jan; 14(2):249-54. PubMed ID: 9010227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.
    Zarkowska T; Mittnacht S
    J Biol Chem; 1997 May; 272(19):12738-46. PubMed ID: 9139732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
    Wallace M; Ball KL
    Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
    Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
    Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for distinct cyclin-dependent kinase activities using phosphorylation-site-specific anti-pRB monoclonal antibodies.
    Suzuki S; Tamai K; Yoshida S
    Anal Biochem; 2002 Feb; 301(1):65-74. PubMed ID: 11811968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
    Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
    Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.
    Fåhraeus R; Paramio JM; Ball KL; Laín S; Lane DP
    Curr Biol; 1996 Jan; 6(1):84-91. PubMed ID: 8805225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes.
    Ericson KK; Krull D; Slomiany P; Grossel MJ
    Mol Cancer Res; 2003 Jul; 1(9):654-64. PubMed ID: 12861051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.
    Pan W; Sun T; Hoess R; Grafstrom R
    Carcinogenesis; 1998 May; 19(5):765-9. PubMed ID: 9635861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
    Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
    Bockstaele L; Bisteau X; Paternot S; Roger PP
    Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four distinct cyclin-dependent kinases phosphorylate histone H1 at all of its growth-related phosphorylation sites.
    Swank RA; Th'ng JP; Guo XW; Valdez J; Bradbury EM; Gurley LR
    Biochemistry; 1997 Nov; 36(45):13761-8. PubMed ID: 9374852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.